基于Dixon的水T1映射用于慢性肝病肝纤维化的脂肪校正评估
这项前瞻性研究纳入81例慢性肝病患者,采用连续反转恢复Look-Locker法结合螺旋读出、Dixon和字典处理的水T1(wT1)映射,以MR弹性成像为参考标准评估显著纤维化。wT1与肝硬度相关性优于T1-MOLLI和ECV映射,在全体队列及PDFF>5%亚组中诊断显著纤维化的AUC分别为0.82和0.84,提示其可作为脂肪校正的肝纤维化标志物。
要点
- wT1在显著纤维化患者中高于无纤维化者(628±82 vs. 546±41 ms,P<0.001)。
- wT1与MRE肝硬度相关性优于T1-MOLLI和ECV(全体队列r=0.67 vs. 0.53 vs. 0.48)。
- PDFF>5%亚组中wT1诊断显著纤维化AUC为0.84,优于T1-MOLLI和ECV的0.70。
核心结论
- 与T1-MOLLI和ECV映射相比,所提出的脂肪校正CIR-LL wT1方法被证明是慢性肝病肝纤维化更稳健的标志物,在存在肝脂肪变时亦然。
研究设计与样本
- 前瞻性研究,连续纳入81例慢性肝病患者(平均年龄50±14岁,32例女性,40例PDFF>5%),采用MRI包括MRE肝硬度、PDFF、T1-MOLLI、ECV和wT1弛豫时间测量,以MRE为参考标准。
诊断标准与关键数值
- 显著纤维化(≥F2)定义为PDFF≤5%患者MRE肝硬度>3.66 kPa或PDFF>5%患者>3.14 kPa;全体队列诊断显著纤维化AUC:wT1 0.82、T1-MOLLI 0.77、ECV 0.73(各P<0.001);PDFF>5%亚组AUC:wT1 0.84(P=0.002)、T1-MOLLI 0.70(P=0.04)、ECV 0.70(P=0.04)。
临床应用与阅片要点
- 作者提出并验证的脂肪校正CIR-LL wT1方法在慢性肝病肝纤维化评估中较T1-MOLLI和ECV映射更稳健,在肝脂肪变存在时亦然。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The diagnostic value of conventional T1 mapping for noninvasive assessment of liver fibrosis is limited in the presence of hepatic steatosis. To evaluate the diagnostic value of water T1 (wT1) with continuous inversion-recovery Look-Locker (CIR-LL) method, integrating spiral readout, Dixon, and dictionary-based processing, for the fat-corrected assessment of hepatic fibrosis in patients with chronic liver disease (CLD).
MATERIALS AND METHODS: In this prospective study, consecutive participants with CLD underwent liver magnetic resonance imaging (MRI), which included assessment of MR-elastography (MRE)-derived liver stiffness, proton density fat fraction (PDFF), T1 relaxation times using modified Look-Locker inversion recovery (T1-MOLLI) and extracellular volume fraction (ECV), and wT1 relaxation times. MRE served as the reference standard to evaluate the diagnostic performance of MRI-based mapping parameters. Significant fibrosis (≥F2) was defined as MRE-derived liver stiffness >3.66 kPa in patients with PDFF≤5%, or >3.14 kPa in patients with PDFF>5%. Statistical analysis included Student t test, receiver operating characteristic (ROC) analysis, and Spearman correlation coefficient.
RESULTS: A total of 81 CLD patients (mean age, 50±14 y; 32 female; 40 patients with PDFF>5%) were included. All measured mapping values were significantly higher in patients with significant fibrosis compared with those without (eg, wT1: 628±82 vs. 546±41 ms, P <0.001). wT1 showed a strong correlation with MRE-derived liver stiffness, outperforming T1-MOLLI and ECV mapping [whole cohort: r =0.67 (wT1) vs. 0.53 (T1-MOLLI) vs. 0.48 (ECV); cohort with PDFF>5%: r =0.69 (wT1) vs. 0.44 (T1) vs. 0.49 (ECV); P <0.05 in each case, respectively]. wT1 had a superior diagnostic performance for the detection of significant fibrosis [whole cohort, area under the curve (AUC): 0.82 (wT1); 0.77 (T1-MOLLI); 0.73 (ECV), P <0.001 in each case; cohort with PDFF>5%, AUC: 0.84, P =0.002 (wT1), 0.70, P =0.04 (T1-MOLLI), 0.70, P =0.04 (ECV)].
CONCLUSION: Compared with T1-MOLLI and ECV mapping, the proposed fat-corrected CIR-LL wT1 method proved to be a more robust marker of hepatic fibrosis in CLD, also in the presence of hepatic steatosis.
引用
- Mesropyan N, Huaroc Moquillaza E, Chang J, et al. Dixon-Based Water T1 Mapping for Fat-Corrected Assessment of Hepatic Fibrosis in Chronic Liver Disease. Invest Radiol. 2026. PMID: 40476782. doi:10.1097/RLI.0000000000001212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。